Martin Schlumpberger's Biography

Martin Schlumpberger, Associate Director, Scientific Applications, QIAGEN

Martin Schlumpberger, joined QIAGEN in Hilden, Germany in 2001. In his current position as Associate Director Sc. Appl. he is responsible for product development for Life Sciences applications in the areas of Exosomes and RNA isolation. Prior to working for QIAGEN, Martin worked as a post-doc at the Institute for Neurodegenerative Diseases at UCSF. He completed his PhD in chemistry, with a strong focus on molecular biology and yeast genetics at the University of Stuttgart in 1996.

Multiple Biomarker Analysis: New Approaches and Workflow Solutions

Wednesday, 27 March 2019 at 14:30

Add to Calendar ▼2019-03-27 14:30:002019-03-27 15:30:00Europe/LondonMultiple Biomarker Analysis: New Approaches and Workflow SolutionsLiquid Biopsies 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Isolation of circulating cell-free biomarkers from different types of body fluids and different entities within these samples, such as circulating tumor cells (CTC) or exosomes and other extracellular vesicles (EVs), poses diverse challenges that need to be addressed. QIAGEN recently released new solutions that include exoRNeasy protocols for isolation of short and long RNAs from EVs in urine, or isolation of cell-free miRNA in higher throughput. Our data demonstrate that utilizing different technology approaches in combined workflows allows collection of meaningful biological data at unprecedented depth, enabling new insights into pathological processes that have a direct impact on clinical research parameters, such as survival statistics.

The applications presented are for molecular biology use only. Not for use in diagnostic procedures.

Add to Calendar ▼2019-03-27 00:00:002019-03-29 00:00:00Europe/LondonLiquid Biopsies 2019Liquid Biopsies 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors